Econazole Nitrate Cream 1% recalled due to labeling mispack
Teligent Pharma is recalling Econazole Nitrate Cream 1% in 85-gram bulk tubes due to incorrect labeling. The product was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a labeling error with no reported illnesses or injuries. The hazard is administrative (labeling mispack) rather than safety-related, placing it in the moderate category for minor labeling issues per the rubric.
Plain-English summary
Teligent Pharma, Inc. is recalling Econazole Nitrate Cream 1% in 85-gram bulk shipper tubes (NDC 52565-022-85) due to a labeling mispack issue. The recalled product was distributed nationwide.
The specific lot affected is Lot # 16630 with an expiration date of 03/2023. A total of 14,688 tubes have been recalled. The product is a prescription-only medication manufactured by Teligent Pharma, Inc. in Buena, New Jersey.
Patients and healthcare providers who have this product should contact Teligent Pharma, Inc. for instructions on the recalled medication.
The recalled product
- Product
- Econazole Nitrate Cream 1%, 85 grams bulk shippers, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-022-85 ; packaged in tubes.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Antifungal
- Hazard
- labeling-error
- mispack
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 16630
- Exp 03/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27